Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5938
-2.5 %
$ 152 M
Market Cap
-3.49
P/E
ADAP - ACCOUNTS PAYABLE
Accounts Payable ADAP - Adaptimmune Therapeutics plc
8.13 M
LAST VALUE
0.09%
2 YEAR CAGR
14.76%
5 YEAR CAGR
23.10%
10 YEAR CAGR